Antibiotic-free selection in biotherapeutics: now and forever - Test2 - elhamkhani - TriplyDB

Antibiotic-free selection in biotherapeutics: now and forever

Antibiotic-free selection in biotherapeutics: now and forever

http://www.wikidata.org/entity/Q27028105

about

Complementation of Arginine Auxotrophy for Genetic Transformation of Coxiella burnetii by Use of a Defined Axenic Medium Non-conventional expression systems for the production of vaccine proteins and immunotherapeutic molecules.'Deadman' and 'Passcode' microbial kill switches for bacterial containment.A novel non-antibiotic, lgt-based selection system for stable maintenance of expression vectors in Escherichia coli and Vibrio cholerae.Molecular Cloning, Structural Modeling and the Production of Soluble Triple-Mutated Diphtheria Toxoid (K51E/G52E/E148K) Co-expressed with Molecular Chaperones in Recombinant Escherichia coli.Establishment of a yeast-based VLP platform for antigen presentation.Clinically Usable Interleukin 12 Plasmid without an Antibiotic Resistance Gene: Functionality and Toxicity Study in Murine Melanoma Model.

P2860

Q37121962-FA1BF13C-DB3A-4F8B-AC06-D4C5087326F8 Q39025466-5BC5CFFD-5FBE-4396-97B7-AF930635A00C Q42686913-91236B0E-23C6-4BAE-880F-25EDCFBB424B Q46244964-AB518A53-1A4F-4992-80BC-2DDADF942A4E Q48096971-065537DB-1477-4B46-BC76-36F2351386C4 Q48103866-0D69C3C8-7B91-4572-96F6-CD3E9C75A459 Q53705456-DE5C3762-023B-4B04-9C4F-43F0AE4DFBA8

P2860

Antibiotic-free selection in biotherapeutics: now and forever

http://www.wikidata.org/entity/Q27028105

description

2015 nî lūn-bûn

@nan

2015 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

name

Antibiotic-free selection in biotherapeutics: now and forever

@ast

Antibiotic-free selection in biotherapeutics: now and forever

@en

Antibiotic-free selection in biotherapeutics: now and forever

@nl

type

label

Antibiotic-free selection in biotherapeutics: now and forever

@ast

Antibiotic-free selection in biotherapeutics: now and forever

@en

Antibiotic-free selection in biotherapeutics: now and forever

@nl

prefLabel

Antibiotic-free selection in biotherapeutics: now and forever

@ast

Antibiotic-free selection in biotherapeutics: now and forever

@en

Antibiotic-free selection in biotherapeutics: now and forever

@nl

P1433

Q27028105-A5B99929-1B90-4FE1-9E4C-B61B14FE60F5

P1476

Q27028105-04DC3D92-F76C-470F-801D-886D4CF0F1B3

P2093

Q27028105-04EED67B-F408-451B-BF82-4D70C7FFDF25

Q27028105-340F0560-3F5C-4999-BD20-99C523A2F04C

Q27028105-FB32DE59-9CD6-4499-9444-3E1D50D0A3AD

P2860

Q27028105-091D2001-62E0-4104-9F58-15B7B7CA3B41

Q27028105-09A8E0C6-2353-4A1F-86B9-068065D5A0F0

Q27028105-0F29394A-EEFF-4FF5-821E-B2D8521BEC9F

Q27028105-0F8DF1B3-4C86-491B-AE5F-213D7209BB64

Q27028105-105B7C9A-1589-49DA-906D-0CAD6367B0A7

Q27028105-11BB9741-8C55-4137-B605-018E69EFEFDC

Q27028105-14A1AEC6-7D53-4D12-BB18-B89D62406335

Q27028105-18794661-07B2-4946-A834-6C94D8E7B5E1

Q27028105-18E0D7BA-93F7-4178-A736-6C384417D9D4

Q27028105-1DA1AD2B-D479-4CB9-BE1A-CFF91D4B7174

P304

Q27028105-EE2F840F-5779-4E26-B968-300CCADB6FF8

P31

Q27028105-3352D391-0E5E-49C0-B62D-194C85E0E287

P356

Q27028105-FD885CAB-8D3A-441C-822F-207D26DA9985

P407

Q27028105-AB6D7A18-87CE-4FC5-81AA-A41368C4523F

P433

Q27028105-592CA9B6-4938-4FD1-8E6C-8DF2CEAF5EC1

P478

Q27028105-D0F078EA-3FEA-4BD2-A986-2F09CF155F86

P577

Q27028105-8ED5B299-BB85-4DEF-80CB-0B5E4A55B49D

P5875

Q27028105-9BFA877D-5AC9-4EF0-9B62-0378888FEE75

P698

Q27028105-516B1604-AA5C-4C8A-9F94-C6FD82CBEA01

P932

Q27028105-CBC216D4-A2B9-41F6-A50F-4AE3145DF447

P356

PATHOGENS4020157

P1433

P1476

Antibiotic-free selection in biotherapeutics: now and forever

@en

P2093

Bettina Werle

http://www.w3.org/2001/XMLSchema#string

Charlotte Mignon

http://www.w3.org/2001/XMLSchema#string

Régis Sodoyer

http://www.w3.org/2001/XMLSchema#string

P2860

Engineering of a plasmid-free Escherichia coli strain for improved in vivo biosynthesis of astaxanthin

Mechanism of postsegregational killing by the hok gene product of the parB system of plasmid R1 and its homology with the relF gene product of the E. coli relB operon

Mini-F plasmid genes that couple host cell division to plasmid proliferation

TADB: a web-based resource for Type 2 toxin-antitoxin loci in bacteria and archaea

Stable inheritance of plasmid R1 requires two different loci

Combining the hok/sok, parDE, and pnd postsegregational killer loci to enhance plasmid stability

Antibiotics: the changing regulatory and pharmaceutical industry paradigm

One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products

Multiple hok genes on the chromosome of Escherichia coli

The hok killer gene family in gram-negative bacteria

P304

157-81

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3390/PATHOGENS4020157

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P577

2015-04-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

274727627

http://www.w3.org/2001/XMLSchema#string

P698

25854922

http://www.w3.org/2001/XMLSchema#string

P932

4493468

http://www.w3.org/2001/XMLSchema#string